Table 1 Summary of 18 genes associated with autosomal recessive CM with robust evidence
From: Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies
Gene | Gene function | Phenotype | Reports | Families | Biallelic cases | Variant classes | Evidence summary | GWAS associations | Mouse knockout phenotypes |
|---|---|---|---|---|---|---|---|---|---|
ALPK3 | Localization of myomesin (M-band and nucleus) | DCM/HCM | 17 | 26 | PTV/missense | Exome (8 trio, 5 proband). Panel (2 trio, 2 proband). Max LOD = 2.9 (ref. 52) | HCM, LV/ECG traits | HCM and DCM features | |
BAG5 | Co-chaperone of proteostasis regulation | DCM | 5 | 6 | PTV | Exome (3 trio, 2 proband) | – | LV dilation and arrhythmogenicity | |
CAP2 | Thin filament protein (actin regulation) | DCM | 3 | 4 | PTV | Exome (2 trio, 1 proband). Max LOD = 1.9 (ref. 62) | – | Severe DCM, conduction anomalies, sudden death | |
FBXO32 | E3 ubiquitin ligase subunit | DCM | 2 | 6 | Missense | Exome (2 trio). Max LOD = 3.4 (ref. 65) | HCM, AF, ECG traits | – | |
FLII | Actin remodeling protein | DCM | 3 | 3 | PTV/missense | Exome (3 trio) | – | Embryonic lethality | |
JPH2 | Junctional membrane complex | DCM | 7 | 7 | PTV/missense | Exome (2 trio, 2 proband). Panel (1 trio, 2 proband) | – | Embryonic lethality | |
KLHL24 | E3 ubiquitin ligase substrate adapter | HCM | 4 | 9 | PTV/missense | Exome (3 trio, 1 proband). Max LOD = 3.6 (ref. 71) | – | – | |
LDB3 | Z-disc protein | DCM | 1 (ref. 73) | 5 | 5 | PTV | Exome (5 trio) | ECG traits | Severe DCM, early death |
LEMD2 | Inner nuclear membrane protein | ACM | 1 (ref. 74) | 2 | 11 | Missense | Exome (2 large pedigrees). Max LOD = 7.3 (estimated)74 | – | DCM-like phenotype with fibrosis and arrhythmia (p.Leu13Arg knock-in) |
LMOD2 | Thin filament protein (actin elongation) | DCM | 5 | 6 | PTV | Exome (4 trio). Panel (1 trio) | – | DCM-like phenotype, early death | |
MYZAP | Intercalated disc protein | DCM | 3 | 8 | PTV | Exome (3 trio) | AF | TAC-induced hypertrophy, HF, increased mortality | |
NRAP | Intercalated disc protein | DCM | 30 | 32 | PTV/missense | Exome (7 trio, 12 proband). Panel (2 trio, 9 proband). RVAS: 1.9% versus 0% (P < 0.00001)19 | ECG traits | – | |
PLEKHM2 | Kinesin transport cargo adapter protein | DCM | 2 | 5 | PTV | Exome (1 trio). Panel (1 trio). Max LOD = 2.8 (estimated)87 | LV traits | – | |
PPA2 | Inorganic pyrophosphatase | DCM/SCD | 32 | 53 | Missense | Exome (21 trio, 3 proband). Panel (8 trio) | – | – | |
PPP1R13L | NF-κB and p53 inhibitor | DCM | 11 | 15 | PTV/missense | Exome (6 trio, 5 proband) | – | Severe and rapidly progressing DCM | |
RPL3L | Muscle-specific ribosomal protein | DCM | 6 | 9 | Missense | Exome (6 trio) | AF | – | |
SLC30A5 | Zinc transporter | CM | 1 (ref. 101) | 2 | 4 | PTV | Exome (2 trio) | – | Sudden death (60%) |
TRIM63 | E3 ubiquitin ligase | HCM | 28 | 32 | PTV/missense | Panel (7 trio, 21 proband). RVAS: 0.4% versus 0% (P = 0.0002)104, 2.1% versus 0% (P = 0.003)25 | Strain, ECG traits | Severe hypertrophy (TAC or TRIM55 double-knockout) |